Itafos (IFOS) investor relations material

Executive summary

• Achieved $558 million in revenue and $159 million in Adjusted EBITDA for 2025, with record production and industry-leading utilization at Conda.

• Q1 2026 revenues rose 5% year-over-year to $142.2 million, driven by higher product prices despite significant input cost inflation, especially for sulfur and sulfuric acid.

• Adjusted EBITDA fell to $18.4 million in Q1 2026 from $39.3 million in Q1 2025, and net income dropped to $1.7 million from $35.9 million, mainly due to higher input costs and the absence of prior year one-time gains.

• Completed mining at Rasmussen Valley, started ore delivery from H1/NDR, and surpassed prior years' EBITDA at Arraias.

• Closed Araxá project sale, funding two special dividends totaling CAD 0.22 per share.

Financial highlights

• Adjusted EBITDA margin was the highest among publicly traded peers in 2025.

• P2O5 production increased 170% and sales rose 115% year-over-year.

• Net leverage ratio decreased to 0.1 at year-end 2025, but rose to 0.3x as of March 31, 2026.

• Liquidity exceeded $150 million at year-end 2025, but was $128.2 million as of March 31, 2026.

• Free cash flow was $(16.7) million in Q1 2026 vs. $31.3 million in Q1 2025.

Outlook and guidance

• Conda sales guidance for 2026: 335,000–355,000 tons P2O5, maintaining nameplate capacity.

• Corporate SG&A expenses expected at $16–20 million; growth capex $23–33 million; maintenance capex $63–83 million for 2026.

• Magnesium reduction project and flotation circuit upgrades at Conda targeted for integration in 2027.

• Arraias to restart SSP production with first sales targeted for 2027 at a 170,000-ton annual run rate.

• Exploration and technical work ongoing to extend mine life and support new NI 43-101 reports.